Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 132 Results

Intervention Indication Therapeutic Area Year Actions
Dupilumab for eosinophilic oesophagitis in paediatric patients Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Eosinophilic oesophagitis Gastroenterology , Immunology 2023 View  |  Download
Durvalumab with bevacizumab and chemotherapy for treating advanced ovarian cancers Bevacizumab (Avastin; R 435; RG 405; RG 435) , Chemotherapy , Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) Ovarian cancer Female Reproductive Cancer 2023 View  |  Download
Durvalumab with carboplatin and paclitaxel with or without olaparib for newly diagnosed advanced or reccurent endometrial cancer Carboplatin (Paraplatin) , Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) , Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281) , Paclitaxel (Taxol; paclitaxel albumin) Endometrial cancer Female Reproductive Cancer 2023 View  |  Download
Durvalumab with fluorouracil, leucovorin, oxaliplatin and docetaxel chemotherapy for neoadjuvant and adjuvant treatment of resectable gastric and gastro-oesophageal junction cancer 5-Fluorouracil , Docetaxel (Taxotere; docetaxel trihydrate; docetaxel anhydrous) , Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) , Leucovorin , Oxaliplatin Gastro-oesophageal junction cancer Gastrointestinal Cancer 2023 View  |  Download
Edaravone for treating amyotrophic lateral sclerosis Edaravone oral (FNP1222) Amyotrophic lateral sclerosis Neurology 2023 View  |  Download
Efgartigimod alfa (subcutaneous injection) for treating generalised myasthenia gravis Efgartigimod alfa (ARGX-113) Myasthenia gravis (MG) Musculoskeletal System 2023 View  |  Download
Eflornithine with lomustine for treating recurrent anaplastic astrocytoma Eflornithine (CPP-1X; Difluoromethylornithine; DFMO; Vaniqa; eflornithine hydrochloride monohydrate) , lomustine Anaplastic astrocytoma Neurological Cancer 2023 View  |  Download
Elafibranor for previously treated primary biliary cholangitis Elafibranor (GFT-505) Primary biliary cholangitis (PBC) Hepatology 2023 View  |  Download
Elexacaftor/tezacaftor/ivacaftor and ivacaftor for treating cystic fibrosis without an F508del mutation and with an ELX/TEZ/IVA-responsive mutation in the CFTR gene in patients aged 6 years and older Ivacaftor (Kalydeco; VX-770) , Kaftrio (fixed dose combination: Elexacaftor; Tezacaftor; Ivacaftor) Cystic fibrosis Genetic Disorders , Respiratory System 2023 View  |  Download
Elinzanetant for the treatment of moderate to severe vasomotor symptoms (hot flashes) associated with the menopause Elinzanetant Post-menopausal vasomotor symptoms Women's Health 2023 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications